Related Experiment Video
Updated: Feb 25, 2026

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Helicobacter pylori infection and atherosclerosis: is there a causal relationship?
1Department of Neurology, Jinling Hospital, Southern Medical University, 305 East Zhongshan Road, Nanjing, Jiangsu, 210002, China.
Insights
This review examines the link between Helicobacter pylori (H. pylori) infection and atherosclerosis. Evidence suggests shared risk factors, not direct causation, explain their coexistence.
Area of Science:
- Cardiovascular Science
- Infectious Disease Epidemiology
Background:
- The coexistence of Helicobacter pylori (H. pylori) infection and atherosclerotic diseases has long suggested a causal link.
- Observed declines in both duodenal ulcer and coronary artery disease epidemics, along with H. pylori detection in plaques, fueled this hypothesis.
Purpose of the Study:
- To critically assess the existing evidence for and against a causal relationship between H. pylori infection and atherosclerosis.
- To clarify the nature of the association between H. pylori and cardiovascular health.
Main Methods:
- Systematic review of epidemiological and clinical studies.
- Analysis of proposed biological mechanisms linking H. pylori to atherosclerosis.
- Evaluation of confounding factors and shared risk factors.
Main Results:
- While some studies suggest H. pylori may contribute through inflammation and dyslipidemia, others refute a direct causal link.
- Evidence indicates shared risk factors like aging, smoking, socioeconomic status, and diet are more likely responsible for the observed coexistence.
- No definitive proof establishes H. pylori eradication as a strategy for atherosclerosis prevention or treatment.
Conclusions:
- The current evidence does not support a direct causal relationship between H. pylori infection and atherosclerosis.
- The association is likely explained by common underlying risk factors.
- Further research is needed to fully elucidate the complex interplay, but H. pylori eradication is not currently indicated for atherosclerosis management.
Abstract:
For many years, the coexistence of Helicobacter pylori (H. pylori) infection and atherosclerotic diseases in a disproportional number of patients has inspired the presumption that a causal relationship exists between the conditions. This presumption was evidenced by the simultaneously declining epidemics of duodenal ulcer and coronary artery diseases in the United States in the past 40 years, and was further evidenced by the detection of H. pylori and their DNA in atherosclerotic plaques. Suggested mechanisms underlying this possible causality include intensified inflammatory stress, dyslipidemia, abnormal glucose metabolism, arterial stiffness, increased blood pressure and malnutrition. However, a causal relationship was disproved by results from other studies, which indicated that common risk factors shared by H. pylori infection and atherosclerosis, such as aging, cigarette smoking, disadvantageous socioeconomic status and high salt intake, may predestine their coexistence. Understanding the nature of the relationship between H. pylori infection and atherosclerosis is of vital importance, because a causality may indicate a possible strategy for preventing and treating atherosclerosis by eradicating H. pylori infection in selected individuals. This review assessed current evidence for and against a causal relationship between H. pylori infection and atherosclerosis.
More Related Videos
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors